Jessica Newcomb

Jessica Newcomb has extensive work experience in the finance and accounting industry. Jessica is currently the Vice President Finance at Tango Therapeutics since August 2022. Prior to that, they held various roles at Acceleron Pharma, including VP of Corporate Controller from January 2021 to May 2022, Sr. Director of Corporate Controller from January 2020 to January 2021, and Director of Accounting from March 2019 to December 2019. Before joining Acceleron Pharma, they worked at Finch Therapeutics Group as an Assistant Controller from June 2018 to February 2019. Jessica has a strong background in finance and accounting, with over a decade of experience as a Senior Manager at EY from August 2007 to June 2018.

Jessica Newcomb completed their Bachelor of Science in Business Administration at Boston College from 2003 to 2007, with a focus on Accounting and Marketing. Jessica then pursued a Master's degree in Accounting at Boston College's Carroll School of Management from 2007 to 2008, earning their MSA.